本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Syndax Pharmaceuticals, Inc.

17.28
-0.8100-4.48%
盤後17.280.00000.00%16:10 EDT
成交量:233.23萬
成交額:4,085.79萬
市值:15.43億
市盈率:-6.88
高:18.11
開:18.08
低:17.25
收:18.09
52周最高:25.59
52周最低:12.99
股本:8,929.71萬
流通股本:8,029.50萬
量比:1.81
換手率:2.90%
股息:- -
股息率:- -
每股收益(TTM):-2.5100
每股收益(LYR):-3.2949
淨資產收益率:-255.93%
總資產收益率:-18.67%
市淨率:102.20
市盈率(LYR):-5.24

資料載入中...

2024/03/18

重要事件披露

Form 8-K - Current report
2024/02/27

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/27

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/08

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/12/20

重要事件披露

Form 8-K - Current report
2023/12/15

重要事件披露

Form 8-K - Current report
2023/12/12

重要事件披露

Form 8-K - Current report
2023/11/29

SEC問詢函

Form CORRESP - Correspondence
2023/11/03

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/03

重要事件披露

Form 8-K - Current report
2023/11/01

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/10/06

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/10/02

重要事件披露

Form 8-K - Current report
2023/08/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/03

重要事件披露

Form 8-K - Current report